Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.34 - $34.28 $1,849 - $2,502
73 Added 0.11%
67,504 $2.17 Million
Q4 2023

Feb 14, 2024

SELL
$25.21 - $34.66 $4,512 - $6,204
-179 Reduced 0.26%
67,431 $1.84 Million
Q3 2023

Nov 14, 2023

SELL
$26.91 - $35.49 $25,187 - $33,218
-936 Reduced 1.37%
67,610 $2.01 Million
Q2 2023

Aug 21, 2023

SELL
$25.15 - $32.86 $45,018 - $58,819
-1,790 Reduced 2.54%
68,546 $2.22 Million
Q1 2023

May 11, 2023

BUY
$17.5 - $25.9 $1.23 Million - $1.82 Million
70,336 New
70,336 $1.82 Million
Q1 2022

May 13, 2022

SELL
$15.23 - $21.47 $2.76 Million - $3.89 Million
-181,319 Closed
0 $0
Q4 2021

Mar 11, 2022

BUY
$21.65 - $27.0 $809,558 - $1.01 Million
37,393 Added 25.98%
181,319 $4.07 Million
Q3 2021

Nov 10, 2021

BUY
$19.51 - $28.7 $2.81 Million - $4.13 Million
143,926 New
143,926 $3.64 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $4.7B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.